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Sutureless Transapical Access and Closure
to Facilitate Transapical Transcatheter
Aortic Valve Implantation
First-in-Human Use
Johannes Blumenstein, MD,* Joerg Kempfert, MD,* Arnaud Van Linden, MD,* Mani Arsalan, MD,*y
Helge Mollmann, MD, PHD,y Won-Keun Kim, MD,*y Thomas Walther, MD, PHD*
Bad Nauheim, Germany75-year-old woman with severe aortic stenosis (European System for Cardiac Operative RiskAEvaluation I [EuroSCORE]: 25%; Society of Thoracic Surgeons Predicted Risk of Morta-lity [STS] score: 6.2%) received transcatheter aortic valve implantation (AVI) by our heart
team. After left-sided mini-thoracotomy, the left ventricle (LV) was punctured. In parallel to this, the
Edwards introducer sheath and dilator were prepared and pre-mounted into the access-and-closure
device (Apica Stabilization and Closure [ASC], Apica, Galway, Ireland) (A). After insertion of the
introducer system, the titanium coil of the introducer system was anchored by rotation into the myo-
cardium (B). The transapical AVI procedure was safely performed through the device (C). Then the
closure cap was introduced and delivered through the system into the titanium coil. Finally, the closure
device provided a blood-tight seal without any bleeding (D). LV angiography revealed no insufﬁciency
of the implant and a normal LV function (E). The patient had an uncomplicated postoperative course.
Discharge and 30-day follow-up echocardiography revealed well-preserved LV function.
